CONMED CFO Todd Garner to depart; transition to Special Advisor through Nov 2026

CONMED Corp

Garner's separation effective by Mar 15, 2026 or upon appointment of new CFO; he will serve as Special Advisor until Nov 2, 2026.
Garner eligible for severance under Executive Severance Plan: 1.5x salary + 1.5x average bonus; equity continues vesting through Separation Date.
Company retained executive search firm for permanent CFO; separation not due to disagreement on operations, policies, financial results.
Garner will receive base salary and pro-rated bonus during advisory period but will not receive annual equity grant in Q1 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.